Ozempic-maker Novo Nordisk, OpenAI announce strategic partnership
Danish pharmaceuticals giant Novo Nordisk, maker of the Ozempic and Wegovy anti-obesity drugs, announced Tuesday a 'strategic partnership' with ChatGPT developer OpenAI to accelera...
Original Source
Read the full article at Dailysabah →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.